메뉴 건너뛰기




Volumn 23, Issue 1, 2014, Pages 144-153

The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TUMOR MARKER;

EID: 84892685623     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0870     Document Type: Article
Times cited : (240)

References (53)
  • 1
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 2
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: An update
    • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 3
    • 84871842819 scopus 로고    scopus 로고
    • Recent advances in CT and MR imaging for evaluation of hepatocellular carcinoma
    • Lee J, Yoon JH, Joo I, Woo H. Recent advances in CT andMR imaging for evaluation of hepatocellular carcinoma. Liver Cancer 2012;1: 22-40.
    • (2012) Liver Cancer , vol.1 , pp. 22-40
    • Lee, J.1    Yoon, J.H.2    Joo, I.3    Woo, H.4
  • 4
    • 54349111702 scopus 로고    scopus 로고
    • Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: A systematic review and meta-analysis
    • Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008;57: 1592-6.
    • (2008) Gut , vol.57 , pp. 1592-1596
    • Silva, M.A.1    Hegab, B.2    Hyde, C.3    Guo, B.4    Buckels, J.A.5    Mirza, D.F.6
  • 5
    • 34548254899 scopus 로고    scopus 로고
    • Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC
    • Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33: 437-47.
    • (2007) Cancer Treat Rev , vol.33 , pp. 437-447
    • Stigliano, R.1    Marelli, L.2    Yu, D.3    Davies, N.4    Patch, D.5    Burroughs, A.K.6
  • 6
    • 0035128185 scopus 로고    scopus 로고
    • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
    • Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
    • (2001) Gut , vol.48 , pp. 251-259
    • Bolondi, L.1    Sofia, S.2    Siringo, S.3    Gaiani, S.4    Casali, A.5    Zironi, G.6
  • 7
    • 0035143887 scopus 로고    scopus 로고
    • The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma
    • Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001;5:145-59.
    • (2001) Clin Liver Dis , vol.5 , pp. 145-159
    • Johnson, P.J.1
  • 8
    • 79952230973 scopus 로고    scopus 로고
    • Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases
    • author reply 1-2
    • Marrero JA, El-Serag HB. Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology 2011;53: 1060-1; author reply 1-2.
    • (2011) Hepatology , vol.53 , pp. 1060-1061
    • Marrero, J.A.1    El-Serag, H.B.2
  • 9
    • 0035056663 scopus 로고    scopus 로고
    • Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status
    • Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-5.
    • (2001) J Hepatol , vol.34 , pp. 570-575
    • Trevisani, F.1    D'Intino, P.E.2    Morselli-Labate, A.M.3    Mazzella, G.4    Accogli, E.5    Caraceni, P.6
  • 10
    • 0024306506 scopus 로고
    • Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin
    • Liebman HA. Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin. Cancer Res 1989;49: 6493-7.
    • (1989) Cancer Res , vol.49 , pp. 6493-6497
    • Liebman, H.A.1
  • 11
    • 0036215258 scopus 로고    scopus 로고
    • Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: A prospective study
    • Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, Fujita N, et al. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 2002;49:235-8.
    • (2002) Hepatogastroenterology , vol.49 , pp. 235-238
    • Ikoma, J.1    Kaito, M.2    Ishihara, T.3    Nakagawa, N.4    Kamei, A.5    Fujita, N.6
  • 12
    • 80053158728 scopus 로고    scopus 로고
    • Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease
    • Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, et al. Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oncol Rep 2011;26:1227-33.
    • (2011) Oncol Rep , vol.26 , pp. 1227-1233
    • Oda, K.1    Ido, A.2    Tamai, T.3    Matsushita, M.4    Kumagai, K.5    Mawatari, S.6
  • 13
    • 84855306790 scopus 로고    scopus 로고
    • Highly sensitive lens culinaris agglutininreactive alpha-fetoprotein: A new tool for the management of hepatocellular carcinoma
    • Toyoda H, Kumada T, Tada T. Highly sensitive lens culinaris agglutininreactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma. Oncology 2011;81 Suppl 1:61-5.
    • (2011) Oncology , vol.81 , Issue.SUPPL. 1 , pp. 61-65
    • Toyoda, H.1    Kumada, T.2    Tada, T.3
  • 14
    • 84874630856 scopus 로고    scopus 로고
    • Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI
    • Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol 2013;7:269-79.
    • (2013) Expert Rev Gastroenterol Hepatol , vol.7 , pp. 269-279
    • Tang, A.1    Cruite, I.2    Sirlin, C.B.3
  • 15
    • 0034122117 scopus 로고    scopus 로고
    • Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
    • Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000;95:1535-8.
    • (2000) Am J Gastroenterol , vol.95 , pp. 1535-1538
    • Gambarin-Gelwan, M.1    Wolf, D.C.2    Shapiro, R.3    Schwartz, M.E.4    Min, A.D.5
  • 16
    • 0036712048 scopus 로고    scopus 로고
    • Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations
    • Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61.
    • (2002) Liver Transpl , vol.8 , pp. 749-761
    • Libbrecht, L.1    Bielen, D.2    Verslype, C.3    Vanbeckevoort, D.4    Pirenne, J.5    Nevens, F.6
  • 17
    • 0037293402 scopus 로고    scopus 로고
    • Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET
    • Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT,MRimaging, US, and PET. Radiology 2003;226:533-42.
    • (2003) Radiology , vol.226 , pp. 533-542
    • Teefey, S.A.1    Hildeboldt, C.C.2    Dehdashti, F.3    Siegel, B.A.4    Peters, M.G.5    Heiken, J.P.6
  • 18
    • 0035722375 scopus 로고    scopus 로고
    • Surveillance for hepatocellular carcinoma in patientswith chronic viral hepatitis in the United States of America
    • Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patientswith chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001;16:553-9.
    • (2001) J Gastroenterol Hepatol , vol.16 , pp. 553-559
    • Tong, M.J.1    Blatt, L.M.2    Kao, V.W.3
  • 19
    • 0034991518 scopus 로고    scopus 로고
    • Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
    • Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403.
    • (2001) Hepatology , vol.33 , pp. 1394-1403
    • Yao, F.Y.1    Ferrell, L.2    Bass, N.M.3    Watson, J.J.4    Bacchetti, P.5    Venook, A.6
  • 20
    • 78751702512 scopus 로고    scopus 로고
    • CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis
    • Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011;9:161-7.
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 161-167
    • Yu, N.C.1    Chaudhari, V.2    Raman, S.S.3    Lassman, C.4    Tong, M.J.5    Busuttil, R.W.6
  • 21
    • 79958185773 scopus 로고    scopus 로고
    • Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA
    • El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut 2011;60:992-7.
    • (2011) Gut , vol.60 , pp. 992-997
    • El-Serag, H.B.1    Kramer, J.R.2    Chen, G.J.3    Duan, Z.4    Richardson, P.A.5    Davila, J.A.6
  • 22
    • 67449107459 scopus 로고    scopus 로고
    • Metaanalysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
    • Singal A, Volk M, Waljee A, Salgia R, Higgins P, Rogers M, et al. Metaanalysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30: 37-47.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 37-47
    • Singal, A.1    Volk, M.2    Waljee, A.3    Salgia, R.4    Higgins, P.5    Rogers, M.6
  • 24
    • 33644553034 scopus 로고    scopus 로고
    • Standards for reporting prognostic tumor marker studies
    • Alonzo TA. Standards for reporting prognostic tumor marker studies. J Clin Oncol 2005;23:9053-4.
    • (2005) J Clin Oncol , vol.23 , pp. 9053-9054
    • Alonzo, T.A.1
  • 25
    • 48549106668 scopus 로고    scopus 로고
    • AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
    • Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, et al. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 2008;8:200.
    • (2008) BMC Cancer , vol.8 , pp. 200
    • Beale, G.1    Chattopadhyay, D.2    Gray, J.3    Stewart, S.4    Hudson, M.5    Day, C.6
  • 29
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 30
    • 0036189111 scopus 로고    scopus 로고
    • Prognostic prediction and treatment strategy in hepatocellular carcinoma
    • Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
    • (2002) Hepatology , vol.35 , pp. 519-524
    • Bruix, J.1    Llovet, J.M.2
  • 31
    • 0345299824 scopus 로고    scopus 로고
    • Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334: 693-700.
    • (1996) N Engl J Med , vol.334 , pp. 693-700
    • Mazzaferro, V.1    Regalia, E.2    Doci, R.3    Andreola, S.4    Pulvirenti, A.5    Bozzetti, F.6
  • 34
    • 64249101592 scopus 로고    scopus 로고
    • Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis
    • Kagebayashi C, Yamaguchi I, Akinaga A, Kitano H, Yokoyama K, Satomura M, et al. Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 2009;388:306-11.
    • (2009) Anal Biochem , vol.388 , pp. 306-311
    • Kagebayashi, C.1    Yamaguchi, I.2    Akinaga, A.3    Kitano, H.4    Yokoyama, K.5    Satomura, M.6
  • 35
    • 0004509186 scopus 로고
    • Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling
    • Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Applied Statistics 1994;43:429-67.
    • (1994) Applied Statistics , vol.43 , pp. 429-467
    • Royston, P.1    Altman, D.G.2
  • 36
    • 80052348326 scopus 로고    scopus 로고
    • Surveillance for hepatocellular carcinoma: In whom and how?
    • El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011;4:5-10.
    • (2011) Therap Adv Gastroenterol , vol.4 , pp. 5-10
    • El-Serag, H.B.1    Davila, J.A.2
  • 37
    • 84866854645 scopus 로고    scopus 로고
    • Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: A brilliant star raises again
    • Lai Q, Melandro F, Pinheiro RS, Donfrancesco A, Fadel BA, Levi Sandri GB, et al. Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again. Int J Hepatol 2012;2012:893103.
    • (2012) Int J Hepatol , vol.2012 , pp. 893103
    • Lai, Q.1    Melandro, F.2    Pinheiro, R.S.3    Donfrancesco, A.4    Fadel, B.A.5    Levi Sandri, G.B.6
  • 38
    • 77949659092 scopus 로고    scopus 로고
    • Serological surveillance for hepatocellular carcinoma: Time to quit
    • Sherman M. Serological surveillance for hepatocellular carcinoma: time to quit. J Hepatol 2010;52:614-5.
    • (2010) J Hepatol , vol.52 , pp. 614-615
    • Sherman, M.1
  • 39
    • 33947157637 scopus 로고    scopus 로고
    • The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: Evaluation in a United States referral population
    • quiz 267
    • Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, et al. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 2007;5:394-402; quiz 267.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 394-402
    • Leerapun, A.1    Suravarapu, S.V.2    Bida, J.P.3    Clark, R.J.4    Sanders, E.L.5    Mettler, T.A.6
  • 40
    • 79954664197 scopus 로고    scopus 로고
    • Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alphafetoprotein < 20 ng/mL
    • Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, et al. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alphafetoprotein < 20 ng/mL. Cancer Sci 2011;102:1025-31.
    • (2011) Cancer Sci , vol.102 , pp. 1025-1031
    • Toyoda, H.1    Kumada, T.2    Tada, T.3    Kaneoka, Y.4    Maeda, A.5    Kanke, F.6
  • 41
    • 34848886470 scopus 로고    scopus 로고
    • Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis
    • Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, et al. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol 2007;102: 2196-205.
    • (2007) Am J Gastroenterol , vol.102 , pp. 2196-2205
    • Sterling, R.K.1    Jeffers, L.2    Gordon, F.3    Sherman, M.4    Venook, A.P.5    Reddy, K.R.6
  • 42
    • 58049200257 scopus 로고    scopus 로고
    • Utility of Lens culinaris agglutinin-reactive fraction of alphafetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma
    • Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, et al. Utility of Lens culinaris agglutinin-reactive fraction of alphafetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009;7:104-13.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 104-113
    • Sterling, R.K.1    Jeffers, L.2    Gordon, F.3    Venook, A.P.4    Reddy, K.R.5    Satomura, S.6
  • 43
    • 47649105803 scopus 로고    scopus 로고
    • Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma
    • Toyoda H, Kumada T, Osaki Y, Oka H, Kudo M. Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma. Hepatol Res 2007;37 Suppl 2: S166-71.
    • (2007) Hepatol Res , vol.37 , Issue.SUPPL. 2
    • Toyoda, H.1    Kumada, T.2    Osaki, Y.3    Oka, H.4    Kudo, M.5
  • 44
    • 39849084412 scopus 로고    scopus 로고
    • Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
    • Yamaguchi I, Nakamura K, Kitano H, Masuda Y, Kanke F, Kobatake S, et al. Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer. Clin Chem Lab Med 2008;46:411-6.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 411-416
    • Yamaguchi, I.1    Nakamura, K.2    Kitano, H.3    Masuda, Y.4    Kanke, F.5    Kobatake, S.6
  • 45
    • 51849127949 scopus 로고    scopus 로고
    • Desgamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma
    • Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, et al. Desgamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2008;23:1541-8.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 1541-1548
    • Durazo, F.A.1    Blatt, L.M.2    Corey, W.G.3    Lin, J.H.4    Han, S.5    Saab, S.6
  • 46
    • 33847231604 scopus 로고    scopus 로고
    • Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States
    • Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci 2007;52:776-82.
    • (2007) Dig Dis Sci , vol.52 , pp. 776-782
    • Carr, B.I.1    Kanke, F.2    Wise, M.3    Satomura, S.4
  • 47
    • 67649305155 scopus 로고    scopus 로고
    • Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
    • Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009;137:110-8.
    • (2009) Gastroenterology , vol.137 , pp. 110-118
    • Marrero, J.A.1    Feng, Z.2    Wang, Y.3    Nguyen, M.H.4    Befeler, A.S.5    Roberts, L.R.6
  • 48
    • 75449103932 scopus 로고    scopus 로고
    • Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
    • Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 2010;138:493-502.
    • (2010) Gastroenterology , vol.138 , pp. 493-502
    • Lok, A.S.1    Sterling, R.K.2    Everhart, J.E.3    Wright, E.C.4    Hoefs, J.C.5    Di Bisceglie, A.M.6
  • 49
    • 79959825606 scopus 로고    scopus 로고
    • Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus
    • Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, et al. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus. J Gastroenterol 2011;46:536-44.
    • (2011) J Gastroenterol , vol.46 , pp. 536-544
    • Kumada, T.1    Toyoda, H.2    Kiriyama, S.3    Tanikawa, M.4    Hisanaga, Y.5    Kanamori, A.6
  • 50
    • 19544389853 scopus 로고    scopus 로고
    • Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3
    • Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005;20:759-64.
    • (2005) J Gastroenterol Hepatol , vol.20 , pp. 759-764
    • Okuda, H.1    Saito, A.2    Shiratori, K.3    Yamamoto, M.4    Takasaki, K.5    Nakano, M.6
  • 51
    • 18144411666 scopus 로고    scopus 로고
    • Updated treatment approach to hepatocellular carcinoma
    • Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005;40:225-35.
    • (2005) J Gastroenterol , vol.40 , pp. 225-235
    • Llovet, J.M.1
  • 52
    • 2942577356 scopus 로고    scopus 로고
    • Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
    • Lin OS, Keeffe EB, Sanders GD, Owens DK. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther 2004;19:1159-72.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 1159-1172
    • Lin, O.S.1    Keeffe, E.B.2    Sanders, G.D.3    Owens, D.K.4
  • 53
    • 3843125293 scopus 로고    scopus 로고
    • Randomized controlled trial of screening for hepatocellular carcinoma
    • Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130: 417-22.
    • (2004) J Cancer Res Clin Oncol , vol.130 , pp. 417-422
    • Zhang, B.H.1    Yang, B.H.2    Tang, Z.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.